![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-announces-clearance-clinical-trial
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-participate-upcoming-march-2024-investor
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-reports-fourth-quarter-and-year-end-2023
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-participate-guggenheim-healthcare-talks-6th
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-appoints-biotech-executive-christi-shaw-its
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-participate-2023-jefferies-london-healthcare
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-reports-pipeline-and-business-updates-and
https://www.fiercebiotech.com/biotech/beam-offloads-verve-rights-lilly-600m-and-more-deals-are-works
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-presents-preclinical-data-highlighting-0
https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-announces-portfolio-prioritization-and